Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 39

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammation

Ugalde, Valentina, Contreras, Francisco, Prado, Carolina, Chovar, Ornella, Espinoza, Alexandra, Pacheco, Rodrigo · 2021 · Mucosal Immunology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41385-020-00354-7

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 66

  1. Granlund, 2013, Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis, PloS ONE, 8, e56818, 10.1371/journal.pone.0056818 · DOI
  2. Olsen, 2011, TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation, Cytokine, 56, 633, 10.1016/j.cyto.2011.08.036 · DOI
  3. Powrie, 1990, OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset, J. Exp. Med, 172, 1701, 10.1084/jem.172.6.1701 · DOI · Paper page
  4. Mair, 2018, A context-dependent role for alphav integrins in regulatory T cell accumulation at sites of inflammation, Front. Immunol., 9, 264, 10.3389/fimmu.2018.00264 · DOI
  5. Huber, 2004, Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells, J. Immunol., 173, 6526, 10.4049/jimmunol.173.11.6526 · DOI · Paper page
  6. Saruta, 2007, Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease, Clin. Immunol., 125, 281, 10.1016/j.clim.2007.08.003 · DOI · Paper page
  7. Maul, 2005, Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease, Gastroenterology, 128, 1868, 10.1053/j.gastro.2005.03.043 · DOI · Paper page
  8. Asano, 2012, Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice, Am. J. Physiol. Gastrointest. Liver Physiol., 303, G1288, 10.1152/ajpgi.00341.2012 · DOI · Paper page
  9. Pacheco, 2014, The dopaminergic system in autoimmune diseases, Front. Immunol., 5, 117, 10.3389/fimmu.2014.00117 · DOI · Paper page
  10. Prado, 2012, Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity, J. Immunol., 188, 3062, 10.4049/jimmunol.1103096 · DOI · Paper page
  11. Cosentino, 2007, Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop, Blood, 109, 632, 10.1182/blood-2006-01-028423 · DOI · Paper page
  12. Magro, 2002, Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease, Dig. Dis. Sci., 47, 216, 10.1023/A:1013256629600 · DOI · Paper page
  13. Magro, 2004, Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-gamma upon L-DOPA uptake, Acta Physiol. Scand., 180, 379, 10.1111/j.1365-201X.2004.01260.x · DOI
  14. Pacheco, 2009, Role of dopamine in the physiology of T-cells and dendritic cells, J. Neuroimmunol., 216, 8, 10.1016/j.jneuroim.2009.07.018 · DOI
  15. Contreras, 2016, Dopamine receptor D3 signaling on CD4+ T cells favors Th1- and Th17-mediated immunity, J. Immunol., 196, 4143, 10.4049/jimmunol.1502420 · DOI
  16. Franz, 2015, Dopamine receptors D3 and D5 regulate CD4(+)T-cell activation and differentiation by modulating ERK activation and cAMP production, J. Neuroimmunol., 284, 18, 10.1016/j.jneuroim.2015.05.003 · DOI
  17. Elgueta, D. et al. Dopamine receptor D3 expression is altered in CD4+ T-cells from Parkinson's disease patients and its pharmacologic inhibition attenuates the motor impairment in a mouse model. Front. Immunol. 10, 981 (2019). · DOI
  18. Shao, 2013, Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alphaB-crystallin, Nature, 494, 90, 10.1038/nature11748 · DOI · Paper page
  19. Torres-Rosas, 2014, Dopamine mediates vagal modulation of the immune system by electroacupuncture, Nat. Med., 20, 291, 10.1038/nm.3479 · DOI · Paper page
  20. Besser, 2005, Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both, J. Neuroimmunol., 169, 161, 10.1016/j.jneuroim.2005.07.013 · DOI · Paper page
  21. Miyazawa, 2003, Dopamine-induced protection against indomethacin-evoked intestinal lesions in rats−role of anti-intestinal motility mediated by D2 receptors, Med. Sci. Monit., 9, BR71
  22. Magro, 2006, Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment, Dig. Dis. Sci., 51, 2039, 10.1007/s10620-006-9168-3 · DOI
  23. Corridoni, 2018, Emerging mechanisms of innate immunity and their translational potential in inflammatory bowel disease, Front. Med., 5, 32, 10.3389/fmed.2018.00032 · DOI
  24. Gerner, 2018, NAD metabolism fuels human and mouse intestinal inflammation, Gut, 67, 1813, 10.1136/gutjnl-2017-314241 · DOI · Paper page
  25. Sainathan, 2008, Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis, Inflamm. Bowel Dis., 14, 88, 10.1002/ibd.20279 · DOI
  26. Moraga-Amaro, 2014, Dopamine receptor D3 deficiency results in chronic depression and anxiety, Behav. Brain Res., 274, 186, 10.1016/j.bbr.2014.07.055 · DOI
  27. McKenna, 2002, Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study, J. Neuroimmunol., 132, 34, 10.1016/S0165-5728(02)00280-1 · DOI · Paper page
  28. Vidal, P. M. & Pacheco, R. Targeting the dopaminergic system in autoimmunity. J. Neuroimmune Pharmacol. 15, 57–73 (2019). · DOI
  29. Ueno, 2018, Th17 plasticity and its relevance to inflammatory bowel disease, J. Autoimmun., 87, 38, 10.1016/j.jaut.2017.12.004 · DOI · Paper page
  30. Owaga, 2015, Th17 cells as potential probiotic therapeutic targets in inflammatory bowel diseases, Int. J. Mol. Sci., 16, 20841, 10.3390/ijms160920841 · DOI
  31. Fontenot, 2005, Regulatory T cell lineage specification by the forkhead transcription factor foxp3, Immunity, 22, 329, 10.1016/j.immuni.2005.01.016 · DOI · Paper page
  32. Ostanin, 2009, T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade, Am. J. Physiol. Gastrointest. Liver Physiol., 296, G135, 10.1152/ajpgi.90462.2008 · DOI · Paper page
  33. Cassani, 2011, Gut-tropic T cells that express integrin alpha4beta7 and CCR9 are required for induction of oral immune tolerance in mice, Gastroenterology, 141, 2109, 10.1053/j.gastro.2011.09.015 · DOI · Paper page
  34. Wan, 2007, Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression, Nature, 445, 766, 10.1038/nature05479 · DOI · Paper page
  35. Karo, 2014, The RAG recombinase dictates functional heterogeneity and cellular fitness in natural killer cells, Cell, 159, 94, 10.1016/j.cell.2014.08.026 · DOI · Paper page
  36. Johansson-Lindbom, 2003, Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant, J. Exp. Med., 198, 963, 10.1084/jem.20031244 · DOI · Paper page
  37. Mora, 2003, Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells, Nature, 424, 88, 10.1038/nature01726 · DOI · Paper page
  38. Kim, 2013, GPR15-mediated homing controls immune homeostasis in the large intestine mucosa, Science, 340, 1456, 10.1126/science.1237013 · DOI · Paper page
  39. Iwata, 2004, Retinoic acid imprints gut-homing specificity on T cells, Immunity, 21, 527, 10.1016/j.immuni.2004.08.011 · DOI · Paper page
  40. Figueroa, C. et al. Inhibition of dopamine receptor D3 signaling in dendritic cells increases antigen cross-presentation to CD8+ T-cells favoring anti-tumor immunity. J. Neuroimmunol. 303, 99–107 (2017). · DOI
  41. Villablanca, E. J. & Mora, J. R. Competitive homing assays to study gut-tropic t cell migration. J. Vis. Exp. 1, 2619 (2011). · doi:10.3791/2619-v
  42. Pacheco, 2017, Targeting dopamine receptor D3 signalling in inflammation, Oncotarget, 8, 7224, 10.18632/oncotarget.14601 · DOI
  43. Gonzalez, 2013, Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease, J. Immunol., 190, 5048, 10.4049/jimmunol.1203121 · DOI
  44. Chen, 2013, Dopamine receptor 3 might be an essential molecule in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity, BMC Neurosci., 14, 10.1186/1471-2202-14-76 · doi:10.1186/1471-2202-14-76
  45. Elgueta, 2017, Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease, Neuropharmacology, 113, 110, 10.1016/j.neuropharm.2016.09.028 · DOI
  46. Montoya, 2019, Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation, J. Neuroinflammation, 16, 10.1186/s12974-019-1652-8 · DOI
  47. Kipnis, 2004, Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration, J. Neurosci., 24, 6133, 10.1523/JNEUROSCI.0600-04.2004 · DOI · Paper page
  48. Burris, 1995, Lack of discrimination by agonists for D2 and D3 dopamine receptors, Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol., 12, 335, 10.1016/0893-133X(94)00099-L · DOI
  49. Pugsley, 1995, Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907, J. Pharm. Exp. Ther., 275, 1355, 10.1016/S0022-3565(25)12192-7 · DOI · Paper page
  50. Sautel, 1995, A functional test identifies dopamine agonists selective for D3 versus D2 receptors, Neuroreport, 6, 329, 10.1097/00001756-199501000-00026 · DOI · Paper page
  51. Merlo, 2011, Distinct effects of pramipexole on the proliferation of adult mouse sub-ventricular zone-derived cells and the appearance of a neuronal phenotype, Neuropharmacology, 60, 892, 10.1016/j.neuropharm.2011.01.026 · doi:10.1016/j.neuropharm.2011.01.026
  52. Cretney, 2018, Characterization of Blimp-1 function in effector regulatory T cells, J. Autoimmun., 91, 73, 10.1016/j.jaut.2018.04.003 · DOI
  53. Zhang, 2016, Adrenomedullin 2 improves early obesity-induced adipose insulin resistance by inhibiting the class II MHC in adipocytes, Diabetes, 65, 2342, 10.2337/db15-1626 · DOI
  54. Basova, 2018, Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection, PloS ONE, 13, e0199861, 10.1371/journal.pone.0199861 · DOI
  55. Espinosa-Oliva, 2014, Role of dopamine in the recruitment of immune cells to the nigro-striatal dopaminergic structures, Neurotoxicology, 41, 89, 10.1016/j.neuro.2014.01.006 · DOI
  56. Watanabe, 2006, Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3, J. Immunol., 176, 848, 10.4049/jimmunol.176.2.848 · DOI · Paper page
  57. Trivedi, 2016, Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity, J. Autoimmun., 68, 98, 10.1016/j.jaut.2016.01.001 · DOI
  58. Souza, 1999, Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease, Gut, 45, 856, 10.1136/gut.45.6.856 · DOI · Paper page
  59. Rivera-Nieves, 2006, Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis, Gastroenterology, 131, 1518, 10.1053/j.gastro.2006.08.031 · DOI
  60. Biswas, 2019, Interfering with leukocyte trafficking in Crohn's disease, Best. Pr. Res Clin. Gastroenterol., 38–39, 101617, 10.1016/j.bpg.2019.05.004 · doi:10.1016/j.bpg.2019.05.004
  61. Sands, 2017, Leukocyte anti-trafficking strategies: current status and future directions, Digestive Dis., 35, 13, 10.1159/000449077 · doi:10.1159/000449077
  62. Joseph, 2002, Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors, Neuroscience, 112, 39, 10.1016/S0306-4522(02)00067-2 · DOI · Paper page
  63. Chen, 2007, Induction of experimental acute ulcerative colitis in rats by administration of dextran sulfate sodium at low concentration followed by intracolonic administration of 30% ethanol, J. Zhejiang Univ. Sci. B, 8, 632, 10.1631/jzus.2007.B0632 · DOI
  64. Menning, 2010, Retinoic acid-induced gut tropism improves the protective capacity of Treg in acute but not in chronic gut inflammation, Eur. J. Immunol., 40, 2539, 10.1002/eji.200939938 · DOI
  65. Stransky, 1998, Oral tolerance induction with altered forms of ovalbumin, Braz. J. Med Biol. Res, 31, 381, 10.1590/S0100-879X1998000300009 · doi:10.1590/s0100-879x1998000300009
  66. Weijtens, 1998, A retroviral vector system ‘STITCH’ in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes, Gene Ther., 5, 1195, 10.1038/sj.gt.3300696 · doi:10.1038/sj.gt.3300696

Cited by

See all 39

Metadata

Authors
Ugalde, V., Contreras, F., Prado, C., Chovar, O., Espinoza, A., & Pacheco, R.
Venue
Mucosal Immunology
Publisher
Elsevier BV
Published
2021-05
Volume
14
Issue
3
Pages
652-666
ISSN
1933-0219
Cited by
39
References
5
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammation. https://app.cochat.ai/papers/10.1038/s41385-020-00354-7
The paper
Ugalde, V., Contreras, F., Prado, C., Chovar, O., Espinoza, A., & Pacheco, R. (2021). Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammation. Mucosal Immunology. https://doi.org/10.1038/s41385-020-00354-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.